Fluorescence investigation of the retinal delivery of hydrophilic compounds via liposomal eyedrops

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 6, 2011, Pages 894-897

  Hironaka, Kohei ^a   Fujisawa, Takuya ^a   Sasaki, Hitoshi ^a   Tozuka, Yuichi ^a   Tsuruma, Kazuhiro ^a   Shimazawa, Masamitsu ^a   Hara, Hideaki ^a   Takeuchi, Hirofumi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

5(6) carboxyfluorescein; Calcium acetate gradient method; Eyedrop; Liposome; Retina

Indexed keywords

6 CARBOXYFLUORESCEIN; CALCIUM ACETATE; DISTEAROYLPHOSPHATIDYLCHOLINE; EYE DROPS; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM ACETATE GRADIENT METHOD; CELL TRANSFER; CHEMICAL PROCEDURES; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG UPTAKE; EPIFLUORESCENCE MICROSCOPY; FLUOROMETRY; HUMAN; HUMAN CELL; HYDROPHILICITY; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; LIPOSOMAL DELIVERY; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; SINGLE DRUG DOSE;

ACETATES; ANIMALS; BIOLOGICAL TRANSPORT; CALCIUM COMPOUNDS; CELL LINE; CONJUNCTIVA; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; FEASIBILITY STUDIES; FLUORESCEINS; FLUORESCENT DYES; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INDICATORS AND REAGENTS; LIPOSOMES; MALE; MICE; MICE, INBRED STRAINS; OPHTHALMIC SOLUTIONS; PHARMACEUTICAL VEHICLES; PHOSPHATIDYLCHOLINES; RETINA;

EID: 79957983189     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.894     Document Type: Article

References (12)

1. Ang G. S., Townend J., Lois N., Invest. Ophthalmol. Vis. Sci., 51, 4781-4787 (2010).
2. Masuda Y., Horiguchi H., Dumoulin S. O., Furuta A., Miyauchi S., Nakadomari S., Wandell B. A., Invest. Ophthalmol. Vis. Sci., 51, 5356-5364 (2010).
3. Yasukawa T., Kimura H., Tabata Y., Ogura Y., Adv. Drug Deliv. Rev., 52, 25-36 (2001).
4. Nagpal K., Singh S. K., Mishra D. N., Chem. Pharm. Bull., 58, 1423-1430 (2010).
5. Hironaka K., Inokuchi Y., Tozuka Y., Shimazawa M., Hara H., Takeuchi H., J. Controlled Release, 136, 247-253 (2009).
6. Inokuchi Y., Hironaka K., Fujisawa T., Tozuka Y., Tsuruma K., Shimazawa M., Takeuchi H., Hara H., Invest. Ophthalmol. Vis. Sci., 51, 3162-3170 (2010).
7. Clerc S., Barenholz Y., Biochim. Biophys. Acta, 1240, 257-265 (1995).
8. Bajoria R., Sooranna S. R., Contractor S. F., Hum. Reprod., 12, 1343-1348 (1997).
9. Hornof M., Toropainen E., Urtti A., Eur. J. Pharm. Biopharm., 60, 207-225 (2005).
10. Hämäläinen K. M., Kananen K., Auriola S., Kontturi K., Urtti A., Invest. Ophthalmol. Vis. Sci., 38, 627-634 (1997).
11. Amrite A. C., Edelhauser H. F., Kompella U. B., Invest. Ophthalmol. Vis. Sci., 49, 320-332 (2008).
12. Muramatsu K., Maitani Y., Takayama K., Nagai T., Drug Dev. Ind. Pharm., 25, 1099-1105 (1999).